Clinical Trial Update: Efficacy of Oral Ivabradine in Patients Presenting With NSTEMI [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluating the efficacy of oral ivabradine in patients presenting with non-ST-elevation myocardial infarction (NSTEMI).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-st-elevation Myocardial Infarction

Drugs mentioned

• IVABRADINE

Snippet

Sponsor: Cairo University | Conditions: NSTEMI | Phase 2, Phase 3 | Status: COMPLETED